Navigation Links
Telik Reports Positive Data Demonstrating Synergy in Combination,and Highly Statistically Significant Effect of Telcyta as,Maintenance Therapy in First-Line Non-Small Cell Lung Cancer

PALO ALTO, Calif., April 17, 2007 /PRNewswire-FirstCall/ -- Telik, Inc. announced the presentation today of results from a Phase 2 clinical trial of the triplet combination of TELCYTA(R) (canfosfamide HCl, TLK286), carboplatin and paclitaxel in the first-line treatment of advanced non-small cell lung cancer. The results include highly statistically and clinically significant improvement in both progression-free survival and overall survival in responding patients who received TELCYTA maintenance therapy as compared with those who did not receive TELCYTA maintenance therapy. The data were presented at the 98th annual meeting of the American Association for Cancer Research (AACR) in Los Angeles.

The multicenter dose-ranging study enrolled 129 patients with Stage IIIB or IV non-small cell lung cancer. Patients received standard doses of carboplatin and paclitaxel and one of four doses of TELCYTA (400, 500, 750 or 1,000 mg/m2) for a planned course of four to six cycles. Patients with objective responses or stable disease following completion of combination therapy could elect to receive every three week maintenance cycles of TELCYTA as monotherapy until disease progression. Outcomes to be evaluated included safety, objective response and disease stabilization rates, progression-free survival and overall survival in the intent-to-treat population, and safety, progression-free survival and overall survival in patients receiving TELCYTA maintenance therapy.

In the intent-to-treat population (n = 129), the overall objective response rate was 34% (95% CI 26%, 43%), including one complete response. Fifty-six patients, or 43%, had disease stabilization, for an overall disease stabilization rate of 77% (95% CI 69%, 84%). Median progression-free survival was 4.9 months, and the overall median survival was 9.6 months.

One hundred patients (77% of enrolled patients) had objective responses or stable disea
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Telik Announces Telcyta Clinical and Preclinical Presentations at AACR Meeting
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
7. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
10. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
11. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
Post Your Comments:
(Date:12/24/2014)... Dec. 23, 2014   Synageva BioPharma Corp. ... company developing therapeutic products for rare disorders, today ... of the Marketing Authorization Application (MAA) for sebelipase ... the company,s request for accelerated assessment, which has ... time.   The MAA, and the ...
(Date:12/24/2014)...  The American Diabetes Association is recommending a ... with diabetes and that all people with diabetes ... in keeping with recent changes to guidelines for ... of Cardiology (ACC) and American Heart Association (AHA). ... changes to the Association,s annual revised Standards of ...
(Date:12/24/2014)... N.C. , Dec. 23, 2014  Endo Pharmaceuticals ... ENDP ) (TSX: ENL), and BioDelivery Sciences International, ... they have submitted a New Drug Application (NDA) for ... Drug Administration (FDA).  Buprenorphine HCl Buccal Film is under ... require daily, around-the-clock, long-term opioid treatment and for which ...
Breaking Medicine Technology:Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5
... 2011 Today, Children,s Hospital at Scott ... and the only stand-alone facility between Dallas and Austin, opened ... used Scott & White,s state-of-the-art Simulation Center for a mock ... housed in Scott & White Hospital-Temple, before moving patients to ...
... 4, 2011 /PRNewswire/ -- PLC Systems Inc. ... technologies, today announced that it had signed an agreement ... to distribute its innovative RenalGuard System™ in France and ... ACIST will be the exclusive distributor of PLC,s RenalGuard® ...
Cached Medicine Technology:Children's Hospital at Scott & White Opens 2Children's Hospital at Scott & White Opens 3Children's Hospital at Scott & White Opens 4PLC Systems Signs ACIST Medical Systems, to Distribute RenalGuard® in France and Germany 2PLC Systems Signs ACIST Medical Systems, to Distribute RenalGuard® in France and Germany 3PLC Systems Signs ACIST Medical Systems, to Distribute RenalGuard® in France and Germany 4
(Date:12/26/2014)... 2014 Parker & Sons, Inc. ... in heating, cooling and plumbing contractor services throughout ... services in 2014 with regard to air-conditioning systems. ... is known for its incredibly hot summers. Working ... intricacies and details of a wide variety of ...
(Date:12/25/2014)... 2014 The click strand ... strength and durability. Today, the business announces a ... valid until Jan. 30, 2015. , Click strand ... hardwood. BambooFlooringChina.com is a well-known brand in the ... to find a reliable bamboo flooring supplier. , ...
(Date:12/25/2014)... 2014 Product liability lawsuits filed in ... ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal ... issued in the U.S. District Court, Northern District of ... open conference on January 7, 2015, at the Paul ... West Palm Beach, Florida. The Conference is scheduled to ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online company supplying ... of discounted prom dresses, most of which are priced ... the company, the promotion is valid until Jan. 22, ... the UK market. , The prom dresses in this ... styles: A-line strapless, empire strapless chiffon, one shoulder, floor-length, ...
(Date:12/25/2014)... sells many bamboo products and the business is famous ... announces big discounts on its bamboo mats , which ... the world’s leader in bamboo flooring. According to the ... 2015. , The bamboo mats are made from well-treated ... the bamboo strips for the mats are boiled and ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
... BETHESDA, Md., Aug. 19 /PRNewswire-Asia/ -- Chindex ... independent American provider of Western,healthcare products and services in ... entered into a contract to supply EUR5 million in,laboratory ... China,s,Qinghai Province. The purchase is being financed by the ...
... , ELM GROVE, Wis., Aug. 19 A webinar on JCAHO ... partment Core Measures: A c hieving Successful Quality Outcomes ... to aid Hospital Emergency Departments in instituting treatment standards as ... CAP patients. Compliance with JCAHO Core Measures produces better outcomes for ...
... warn of toxic buildup from paraffin, suggest beeswax instead ... candles, used mainly for romantic ambiance, fragrance and light, ... , The candles, which are made from petroleum, are ... researchers said in a study to be presented Wednesday ...
... , WASHINGTON, Aug. 19 The ... Tobacco-Free Kids: , , (Logo: http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ... and Drug Administration announcement today that it is establishing the Center ... highly respected and experienced public health leader, as the Center Director ...
... , , , ... and Prevention (CDC)(1) and LYSOL(R) brand products are proud to announce the launch ... www.oop k i ds.com , an interactive site ... was created in a continued effort to educate children and their parents about ...
... workers, new federal guidelines say , WEDNESDAY, Aug. 19 ... keeping employees six-feet apart are all ways to reduce ... America,s businesses, government experts said in new guidelines issued ... as the fall/winter flu season approaches, because the extent ...
Cached Medicine News:Health News:Chindex International, Inc. Announces New CDC Contract 2Health News:Chindex International, Inc. Announces New CDC Contract 3Health News:Compirion Hosts Free Webinar on Achieving JCAHO-Compliant Quality Outcomes 2Health News:Compirion Hosts Free Webinar on Achieving JCAHO-Compliant Quality Outcomes 3Health News:Tobacco-Free Kids Welcomes Formation of FDA's Center for Tobacco Products and Selection of Center Director 2Health News:The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 2Health News:The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 3Health News:The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 4Health News:Businesses Need Swine Flu Action Plan: Experts 2Health News:Businesses Need Swine Flu Action Plan: Experts 3
For the quantitative in vitro determination of Digoxin in human serum....
For the quantitative in vitro determination of Microalbumin in urine....
Quantitative determination of Fibrinogen (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium....
Determination of Prothrombin Time (PT)by STA Analyzers (ISI~1.8).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
Medicine Products: